Through the Smad pathway, TGF-β increases the expression of high-mobility group A2 (HMGA2) protein which regulates the expression of repressors that downregulate the transcription of E-cadherin during the EMT of tumor cells [119]. The gene discussed is TGFB1; the disease is neoplasm.